Function-Oriented Synthesis of a Didesmethyl Triazacryptand Analogue
(ESI): m/z = 226.2 [M + H]+. HRMS (ESI): calcd. for C10H12NO5
966.4778; found 465.7542 [M + H – Cl–]2+. Purity was found to be
99% on the basis of HPLC analysis.
+
226.0710; found 226.0706. Purity was found to be 98% on the basis
of HPLC analysis.
ddTAC-Lime (3c): ddTAC-Lime 3c was synthesized in 58% yield
from ddTAC-CHO 3a by using the TAC-Lime protocol that is de-
scribed elsewhere.[8] 1H NMR (500 MHz, [D6]DMSO/D2O = 1:1,
25 °C): δ = 6.66–6.52 (m, 9 H), 6.42–6.39 (m, 8 H), 6.27 (s, 1 H),
5.52 (s, 2 H), 3.51–3.34 (m, 24 H), 3.23 (s, 3 H), 2.62–2.58 (m, 24
H), 2.10 (s, 6 H), 1.94 (s, 6 H) ppm. 13C NMR (125 MHz, [D6]-
DMSO/D2O = 1:1, 25 °C): δ = 145.6, 144.4, 136.6, 136.1, 126.9,
126.7, 119.8, 119.6, 118.9, 117.01, 116.96, 115.1, 114.9, 114.7,
113.8, 113.6, 107.21, 107.18, 74.1, 70.10, 70.07, 60.4, 60.3, 58.3,
51.6, 49.1, 13.0, 12.9, 12.2 ppm. MS (ESI): m/z = 912.7 [M + H]+.
4-Amino-3-(2-methoxyethoxy)benzaldehyde (10): Nitrobenzene 9
(500 mg, 2.22 mmol) was dissolved in methanol (300 mL) followed
by the addition of tin(II) chloride dihydrate (15.01 g, 66.7 mmol).
This reaction mixture was heated at reflux for 6 h and then cooled
to ambient temperature. The solution was concentrated and then
dissolved in ethyl acetate (200 mL). The solution was washed with
saturated aq. NaHCO3 (3ϫ100 mL), dried (MgSO4), and concen-
trated to afford 10 (795 mg, 68%) as a light yellow solid. 1H NMR
(300 MHz, [D6]DMSO, 25 °C): δ = 9.70 (s, 1 H), 7.29 (d, J = 2 Hz,
1 H), 7.27–7.23 (m, 1 H), 6.92 (d, J = 4 Hz, 1 H), 3.49 (t, J =
6.5 Hz, 2 H), 3.35–3.32 (m, 2 H), 3.24 (s, 3 H) ppm. 13C NMR
(75 MHz, [D6]DMSO, 25 °C): δ = 191.0, 152.1, 145.8, 128.8, 124.4,
115.5, 114.3, 73.8, 60.0, 58.0 ppm. MS (ESI): m/z = 196.1 [M +
+
HRMS (ESI): calcd. for C50H65BF2N5O8 912.4889; found
912.4894. Purity was found to be 100% on the basis of HPLC
analysis.
Supporting Information (see footnote on the first page of this arti-
cle): NMR spectra of all new compounds and tabulated fluores-
cence emission values for the graphs shown in Figure 3.
+
H]+. HRMS (ESI): calcd. for C10H14NO3 196.0968; found
196.0970. Purity was found to be 97% on the basis of HPLC analy-
sis.
ddTAC-CHO (3a): A solution of aniline 10 (50 mg, 0.256 mmol) in
concentrated HCl (2 mL) was cooled to 0 °C. A solution of NaNO2
(17 mg, 0.256 mmol) in H2O (3 mL) was added, and the mixture
was stirred at 0 °C for 1 h. This mixture, presumably containing
diazonium salt 8, was added dropwise over 30 min to a solution of
7 (131 mg, 0.256 mmol) in CH3CN (10 mL) at 0 °C. The reaction
mixture was warmed to 25 °C, and the solution was stirred at this
temperature for 12 h. The mixture was slowly diluted with satu-
rated aqueous sodium hydrogen carbonate (75 mL) and extracted
with diethyl ether (3ϫ100 mL). The combined extracts were
washed with brine (100 mL), dried (MgSO4), and concentrated.
This residue was purified by column chromatography (hexane/
EtOAc, 90:10) to afford 3a (147 mg, 83%) as a light-brown solid:
1H NMR (300 MHz, CDCl3, 25 °C): δ = 9.69 (s, 1 H), 7.48–7.08
(m, 3 H), 6.79–6.58 (m, 8 H), 3.73–3.48 (m, 24 H), 3.39 (s, 3 H),
2.82–2.74 (m, 12 H) ppm. 13C NMR (75 MHz, CDCl3, 25 °C): δ =
191.0, 155.5, 148.0, 147.5, 145.0, 136.9, 135.5, 128.2, 125.6, 120.1,
119.0, 116.0, 115.8, 115.3, 113.7, 69.4, 68.9, 60.8, 50.8, 49.2 ppm.
MS (ESI): m/z = 694.5 [M + H]+. HRMS (ESI): calcd. for
Acknowledgments
This work was supported by the National Institutes of Health
(NIH) (grants EB00415, DK86125, DK35124, HL73856, EY13574,
and DK72517), the Cystic Fibrosis Foundation, and the Guthy–
Jackson Charitable Foundation.
[1] K. Hiratani, M. Albrecht, Chem. Soc. Rev. 2008, 37, 2413–
2421.
[2] P. Metrangolo, F. Meyer, T. Pilati, G. Resnati, G. Terraneo,
Angew. Chem. 2008, 120, 6206–6220; Angew. Chem. Int. Ed.
2008, 47, 6114–6127.
[3] H. Maeda, Eur. J. Org. Chem. 2007, 5313–5325.
[4] T. Enoki, A. Miyazaki, Chem. Rev. 2004, 104, 5449–5477.
[5] J. K. McCusker, Acc. Chem. Res. 2003, 36, 876–887.
[6] S. V. Rosokha, J. K. Kochi, J. Org. Chem. 2002, 67, 1727–1737.
[7] X. Duan, L. Liu, F. Feng, S. Wang, Acc. Chem. Res. 2010, 43,
260–270.
[8] E. M. Nolan, S. J. Lippard, Chem. Rev. 2008, 108, 3443–3480.
[9] B. Valeur, I. Leray, Coord. Chem. Rev. 2000, 205, 3–40.
[10] H. He, M. A. Mortellaro, M. J. P. Leiner, R. J. Fratz, J. K.
Tusa, J. Am. Chem. Soc. 2003, 125, 1468–1469.
[11] M. Magzoub, P. Padmawar, J. A. Dix, A. S. Verkman, J. Phys.
Chem. B 2006, 110, 21216–21221.
+
C38H52N3O9 694.3698; found 694.3693. Purity was found to be
98% on the basis of HPLC analysis.
ddTAC-Red (3b): In a sealable microwave vial, ddTAC-CHO 3a
(15 mg, 21.6 μmol) and 3-dimethylaminophenol (6.5 mg,
47.6 μmol) were dissolved in acetic acid (1 mL). A catalytic amount
of p-toluenesulfonic acid (PTSA) was then added, and the vial was
sealed and microwave irradiated at 130 °C for 5 min. After cooling,
the reaction mixture was treated with 3 m sodium acetate in water
and the precipitated solid was collected by centrifugation, washed
with water and dried, giving a reddish-brown solid. This solid was
then dissolved in methanol/chloroform (3:1, 1 mL) and transferred
to a sealable microwave vial. Tetrachloro-1,4-benzoquinone (11 mg,
[12] P. Padmawar, X. Yao, O. Bloch, G. T. Manley, A. S. Verkman,
Nat. Methods 2005, 2, 825–827.
[13] W. Namkung, Y. Song, A. D. Mills, P. Padmawar, W. E. Fink-
beiner, A. S. Verkman, J. Biol. Chem. 2009, 284, 15916–15926.
[14] W. Namkung, P. Padmawar, A. D. Mills, A. S. Verkman, J. Am.
Chem. Soc. 2008, 130, 7794–7795.
[15] R. D. Carpenter, A. S. Verkman, Org. Lett. 2010, 12, 1160–
1163.
43.2 μmol) was then added, and the vial was sealed and microwave
irradiated at 115 °C for 18 min. The reaction mixture was then fil-
tered, and the filtrate was concentrated. The residue was dissolved
in a minimal volume of ether, precipitated with a saturated solution
of hydrogen chloride in ether, and filtered to afford ddTAC-Red
(3b) as a dark solid (12 mg, 62% from ddTAC-CHO 3a). 1H NMR
(500 MHz, [D6]DMSO/D2O = 1:1, 25 °C): δ = 6.65–6.52 (m, 9 H),
6.43–6.40 (m, 8 H), 3.48–3.23 (m, 24 H), 3.21 (s, 3 H), 2.82–2.59 (m,
24 H) ppm. 13C NMR (125 MHz, [D6]DMSO/D2O = 1:1, 25 °C): δ
= 145.8, 144.6, 136.6, 136.1, 120.3, 119.5, 117.8, 115.5, 115.0, 114.7,
74.2, 70.3, 70.0, 60.6, 58.6, 51.4, 49.0, 40.7 ppm. MS (ESI): m/z =
[16] J.-P. Lellouche, V. Kotlyar, Synlett 2004, 564–571.
[17] Tasneem, Synlett 2003, 138–139.
[18] P. A. Wender, V. A. Verma, T. J. Paxton, T. H. Pillow, Acc.
Chem. Res. 2008, 41, 40–49.
[19] P. A. Wender, B. L. Miller, Nature 2009, 460, 197–201.
[20] B. U. W. Maes, J. Kosmrlj, G. L. F. Lemiere, J. Heterocycl.
Chem. 2002, 39, 535–543.
[21] N. Narender, P. Srinivasu, S. J. Kulkarni, Synth. Commun.
2002, 32, 2319–2324.
[22] C. A. Townsend, L. M. Bloom, Tetrahedron Lett. 2001, 22,
3923–3924.
[23] R. S. Coleman, J. M. Guernon, J. T. Roland, Org. Lett. 2000,
465.8 [M + H – Cl–]2+. HRMS (ESI): calcd. for C54H69ClN5O9
2, 277–280.
+
Eur. J. Org. Chem. 2011, 1242–1248
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
1247